Results 171 to 180 of about 25,780 (241)

High-Risk neuroblastoma therapeutics Topotecan and 13-cis-Retinoic acid modulate autophagy and induce DNA damage response in hematopoietic stem cells and monocytes. [PDF]

Sci Rep
Lázničková P, Tidu F, Hrdý J, Boráková K, Hortová Kohoutková M, Frič J.   +5 more
europepmc   +1 more source

A New Era of Treatment Sequencing in Platinum-Resistant Ovarian Cancer: Integrating Immunotherapy, Antibody-Drug Conjugates, and Targeted Therapies. [PDF]

Curr Oncol
Mabuchi S, Kusakabe A, Takimoto Y.
europepmc   +1 more source

Inclusion of JNK-independent drugs within multiagent chemotherapy improves response in relapsed high-risk neuroblastoma. [PDF]

Sci Adv
Han JZR, Phimmachanh M, Hastings JF, Leong KH, Ng BH, Ni J, Fontaine-Titley A, Cadell AL, O'Donnell YE, Clearwater M, Kamili A, Haber M, Norris M, Timpson P, Trahair TN, Fletcher JI, Fey D, Kolch W, Latham SL, Croucher DR.   +19 more
europepmc   +1 more source

Treatment Sequencing in Platinum-Resistant Epithelial Ovarian Cancer After MIRASOL, KEYNOTE-B96, and ROSELLA. [PDF]

Int J Womens Health
Liu Y, Xu M, Ma J, Zhu Y, Gao M.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

A Real-World Data Analysis of Topotecan in the FDA Adverse Event Reporting System (FAERS) Database

Expert Opinion on Drug Metabolism and Toxicology, 2023
Objectives The objective of this study was to monitor and identify adverse events (AEs) associated with topotecan, a medication used for the treatment of solid tumors, in order to improve patient safety and guide medication usage.
Bin Zhao, Zheng Wan
exaly   +2 more sources

A New Electrochemical DNA Biosensor Based on Modified Carbon Paste Electrode Using Graphene Quantum Dots and Ionic Liquid for Determination of Topotecan

Microchemical Journal, 2019
To study topotecan–DNA interaction and topotecan determination with a modified carbon paste electrode (CPE), a new electrochemical biosensor is introduced.
Somayeh Tajik, Hadi Mahmoudi-Moghaddam, Hadi Beitollahi   +2 more
exaly   +2 more sources

Intravitreal Topotecan 90 µg for Recurrent Solid Retinoblastoma Tumors Is Effective and Not Toxic.

Journal of pediatric ophthalmology and strabismus, 2023
The authors report on the safety and efficacy of 90 µg/0.18 cc of intravitreal topotecan for recurrent solid retinal tumors in retinoblastoma. Topotecan 90 µg was injected intravitreally in three retinoblastoma cases that progressed after prior therapy ...
D. Abramson, J. Francis
semanticscholar   +1 more source